ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO141

Dietary Acid Reduction with Either Fruits and Vegetables or Oral NaHCO3 Reduces Oxidative Stress and Slows Progression of Kidney Injury in Stage 1 CKD

Session Information

Category: Nutrition, Inflammation, and Metabolism

  • 1401 Nutrition, Inflammation, Metabolism


  • Goraya, Nimrit, Baylor Scott and White Health, Temple, Texas, United States
  • Sager, Lauren N, Baylor Scott & White, Temple, Texas, United States
  • Simoni, Jan, Baylor Scott & White Health, Temple, Texas, United States
  • Wesson, Donald E., Diabetes Health and Wellness Institute, Dallas, Texas, United States

Chronic kidney disease stage 1 (eGFR > 90 ml/min/m2, CKD 1) patients with macroalbuminuria (urine albumin-to-creatinine ratio > 200 mg/g creatinine) are at increased risk for CKD progression with higher morbidity, mortality, and costs. Dietary acid (H+) induces nephropathy progression in animal models of CKD, mediated in part though angiotensin II (AII)-induced oxidative stress. We tested the hypothesis that dietary H+ reduction with base-producing fruits and vegetables (F+V) or oral NaHCO3 (HCO3) prevents further kidney injury in CKD 1.


Seventy-one macroalbuminuric, non-diabetic CKD 1 subjects had systolic blood pressure (SBP) reduced to < 150 mm Hg with regimens including ACE inhibition and were then randomized to receive F+V (n=23) in amounts to reduce dietary potential renal acid load by half, oral NaHCO3 (HCO3, n=23) 0.4 meq/Kg bw/day, or no additional intervention (Usual Care, n=25). Creatinine-based eGFR and spot urine levels of the following, factored per g creatinine, were measured at baseline and yearly for five years: albumin (Ualb), an index of kidney injury, angiotensinogen (UAGT), an index of kidney angiotensin II, and isoprostane 8-isoprostaglandin F2a (8-iso), an index of oxidative stress.


Baseline eGFR, Ualb, UAGT, and U8-iso were not different among the groups. The five-year course (mean, 95% confidence limit or CI) of Ualb was lower than Usual Care (406 mg/g, CI=376-435) in both F+V (332 mg/g, CI=312-352) and HCO3 (324 mg/g, CI=299-349), consistent with less kidney injury in each dietary acid reduction group. Combining F+V and HCO3 into one dietary acid reduction group, UAGT course was lower than Usual Care (p<0.02), consistent with lower kidney AII. The five-year course of U8-iso was lower than Usual Care (1.24 ug/g, CI=1.19-1.29) in both F+V (1.10 ug/g, CI=1.06-1.15) and HCO3 (1.11 ug/g, CI=1.07-1.14), consistent with less oxidative stress in both dietary reduction groups. There was no significant change in eGFR over the five years in any of the three groups.


Dietary acid reduction in CKD 1 with either F+V or NaHCO3 yielded less kidney injury and less oxidative stress than Usual Care, possibly mediated though reduced kidney AII, supporting that dietary acid reduction reduces the risk for progression to advanced CKD stages .